Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJID (2) J. Venom. Anim. Toxins incl. Trop. Dis. (1) Autor Abati,Paulo Afonso Martins (1) Abrão Ferreira,Paulo Roberto (1) Barut,Sener (1) Brandão Mello,Carlos Eduardo (1) Coelho,Henrique Sergio M. (1) Delicio,Adriane Maira (1) Erkorkmaz,Unal (1) Gunal,Ozgur (1) Ruiz,Fernando José Goes (1) Silva,Giovanni Faria (1) Soares,Elza Cotrim (1) Vigani,Aline Gonzalez (1) Villela-Nogueira,Cristiane A. (1) Yildiz,Feyza (1) Mais... Palavra-chave Peginterferon (3) Advanced fibrosis (1) Chronic hepatitis C (1) HBsAg (1) HIV (1) Hepatitis B (1) Hepatitis C (1) Ribavirin (1) Sustained virologic response (1) Thyroid dysfunction (1) Mais... Tipo do documento Info:eu-repo/semantics/article (2) Info:eu-repo/semantics/report (1) Ano 2014 (1) 2013 (1) 2012 (1) País Brazil (3) Idioma Inglês (3)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 3 Primeira ... 1 ... Última Peginterferon plus ribavirin and sustained virological response rate in HCV-related advanced fibrosis: a real life study BJID Silva,Giovanni Faria; Villela-Nogueira,Cristiane A.; Brandão Mello,Carlos Eduardo; Soares,Elza Cotrim; Coelho,Henrique Sergio M.; Abrão Ferreira,Paulo Roberto; Ruiz,Fernando José Goes. Background:Tolerance and response to antiviral HCV treatment is poor in advanced fibrosis. The aim of this study was to assess SVR rate and its predictive factors in HCV advanced fibrosis patients treated in real life with full dose PEG-IFN plus RBV and to evaluate the adverse events related to treatment.Methods:A multicentric, retrospective study was conducted at six university hospitals. METAVIR F3 and F4 HCV monoinfected patients who were treated with PEG-IFN and RBV had their data analyzed. A stepwise logistic regression analysis was performed to identify the variables independently related to SVR. Adverse events were recorded during treatment.Results:308 patients were included, 75% genotype 1 and 23% genotype 3. METAVIR F3 was present in 39% and F4 in... Tipo: Info:eu-repo/semantics/article Palavras-chave: Hepatitis C; Advanced fibrosis; Peginterferon; Ribavirin. Ano: 2014 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702014000100048 Thyroid dysfunction in Turkish patients with chronic hepatitis C receiving peginterferon plus ribavirin in the period of 2005-2010 BJID Barut,Sener; Gunal,Ozgur; Erkorkmaz,Unal; Yildiz,Feyza. Interferon-α based therapy for chronic hepatitis C (CHC) is associated with thyroiditis and thyroid dysfunction (TD). This study investigated whether TD during pegylated interferon-a (PEG-IFN) plus ribavirin treatment favors sustained viral response (SVR), and also the association between TD and PEG-IFN formulations. This retrospective study was performed in CHC patients who had received PEG-IFN plus ribavirin and had been followed for six months after treatment. Several factors were compared between patients with and without TD. 119 patients were included in the study. De novo incidence of TD was found to be 16.8%, and 16 of the 18 patients with TD achieved SVR. Although this rate was higher than patients without TD according to univariate analysis,... Tipo: Info:eu-repo/semantics/article Palavras-chave: Chronic hepatitis C; Peginterferon; Thyroid dysfunction; Sustained virologic response. Ano: 2012 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000500008 Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report J. Venom. Anim. Toxins incl. Trop. Dis. Delicio,Adriane Maira; Abati,Paulo Afonso Martins; Vigani,Aline Gonzalez. Hepatitis B virus (HBV) infects from 6 to 14% of HIV-infected individuals. Concurrent HIV/HBV infection occurs due to the overlapping routes of transmission, particularly sexual and parenteral. HIV-infected patients that have acute hepatitis B have six times greater risk of developing chronic hepatitis B, with higher viral replication, rapid progression to end-stage liver disease and shorter survival. The coinfection is also associated with poor response to hepatitis B treatment with interferon-alpha and increased liver toxicity to the antiretroviral therapy. Herein, we describe the case of a 35-year-old man who engages in sex with men and presented with newly diagnosed HIV-1, serological markers for acute hepatitis B and progression to chronic hepatitis B... Tipo: Info:eu-repo/semantics/report Palavras-chave: HIV; Hepatitis B; HBsAg; Peginterferon. Ano: 2013 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992013000100503 Registros recuperados: 3 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco